-transparent.png){kind=logo}
Angiogenesis is the process of generating new blood vessels from preexisting vessels and is considered essential in many pathological conditions. The purpose of the present study is to evaluate the effect of aspartame on angiogenesis in vivo chick chorioallantoic membrane (CAM) and wound-healing models as well as in vitro 2,3-bis-2H-tetrazolium-5-carboxanilide (XTT) and tube formation assays. In CAM assay, aspartame increased angiogenesis in a concentration-dependent manner. Compared with the control group, aspartame has significantly increased vessel proliferation (p < 0.001). In addition, in vivo rat model of skin wound-healing study showed that aspartame group had better healing than control group, and this was statistically significant at p < 0.05. There was a slight proliferative effect of aspartame on human umbilical vein endothelial cells on XTT assay in vitro, but it was not statistically significant; and there was no antiangiogenic effect of aspartame on tube formation assay in vitro. These results provide evidence that aspartame induces angiogenesis in vitro and in vivo; so regular use may have undesirable effect on susceptible cases.
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
December 2005,
Biological & pharmaceutical bulletin,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
August 1999,
Arteriosclerosis, thrombosis, and vascular biology,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
February 2011,
Toxicology in vitro : an international journal published in association with BIBRA,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
January 2005,
Methods in molecular biology (Clifton, N.J.),
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
January 2001,
Therapie,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
July 2015,
The Journal of pharmacology and experimental therapeutics,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
January 2004,
Methods in molecular biology (Clifton, N.J.),
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
November 2009,
Current molecular medicine,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
January 2006,
Journal of cellular and molecular medicine,
F Yesildal, and
F N Aydin, and
S Deveci, and
S Tekin, and
I Aydin, and
R Mammadov, and
O Fermanli, and
F Avcu, and
C H Acikel, and
T Ozgurtas
April 2001,
Cancer research,
